Liew Tau Ming, Feng Lei, Gao Qi, Ng Tze Pin, Yap Philip
Department of Geriatric Psychiatry, Institute of Mental Health, Singapore.
Gerontology Research Program, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
J Am Med Dir Assoc. 2015 Feb;16(2):144-8. doi: 10.1016/j.jamda.2014.07.021. Epub 2014 Oct 3.
The Montreal Cognitive Assessment (MOCA) is a screening tool for mild cognitive impairment (MCI) and dementia. The new criteria for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) mild neurocognitive disorder (NCD) define participants with cognitive decline but no dementia, and major NCD (dementia). We explored the usefulness of MOCA to detect major and mild NCD.
Cross-sectional test research.
Tertiary hospital memory clinic and community-based Singapore Longitudinal Aging Study (SLAS).
Participants with questionable dementia (clinical dementia rating, CDR = 0.5) and early dementia (CDR ≤1) over a period of 1 year were identified from the memory clinic registry. The patient records were reviewed and the diagnostic labels of major and mild NCD were applied accordingly. Healthy controls (HC) (CDR = 0, Mini-Mental State Examination >26) were recruited from the on-going SLAS.
Major and mild NCD were diagnosed based on medical history, clinical examination, basic and instrumental activities of daily living, locally validated bedside cognitive tests (Mini-Mental State Examination, Frontal Assessment Battery, and Clock Drawing Test), relevant laboratory investigations and standardized neuropsychological assessment.
Two hundred fifty-one participants were included (41 mild NCD, 64 major NCD, 146 HC). On receiver operating characteristic curve analysis, the diagnostic performance by area under the curve (AUC) for MOCA was 0.99 [95% confidence interval (CI) 0.98-1.0] for major NCD and 0.77 (95% CI 0.67-0.86) for mild NCD. For diagnosis of mild NCD, MOCA performed better in those with lower education (primary and below) (AUC 0.90) compared with those with secondary education and beyond (AUC 0.66).
MOCA has high diagnostic utility for major NCD but its usefulness in detecting mild NCD is more modest. Possible reasons include greater heterogeneity in participants with mild NCD and how "quantified clinical assessment" in the DSM-5 mild NCD criteria is interpreted and operationalized.
蒙特利尔认知评估量表(MOCA)是一种用于筛查轻度认知障碍(MCI)和痴呆症的工具。《精神疾病诊断与统计手册》第五版(DSM-5)中轻度神经认知障碍(NCD)的新标准定义了有认知功能下降但无痴呆症的参与者,以及重度NCD(痴呆症)。我们探讨了MOCA在检测重度和轻度NCD方面的有效性。
横断面测试研究。
三级医院记忆门诊和基于社区的新加坡纵向衰老研究(SLAS)。
从记忆门诊登记处确定了在1年期间有可疑痴呆症(临床痴呆评定量表,CDR = 0.5)和早期痴呆症(CDR≤1)的参与者。对患者记录进行了审查,并相应地应用了重度和轻度NCD的诊断标签。健康对照(HC)(CDR = 0,简易精神状态检查表>26)从正在进行的SLAS中招募。
根据病史、临床检查、基本和工具性日常生活活动、本地验证的床边认知测试(简易精神状态检查表、额叶评估量表和画钟试验)、相关实验室检查和标准化神经心理学评估来诊断重度和轻度NCD。
纳入了251名参与者(41名轻度NCD,64名重度NCD,146名HC)。在接受者操作特征曲线分析中,MOCA对重度NCD的曲线下面积(AUC)诊断性能为0.99 [95%置信区间(CI)0.98 - 1.0],对轻度NCD为0.77(95% CI 0.67 - 0.86)。对于轻度NCD的诊断,与受过中等及以上教育的人(AUC 0.66)相比,MOCA在受教育程度较低(小学及以下)的人群中表现更好(AUC 0.90)。
MOCA对重度NCD具有较高的诊断效用,但在检测轻度NCD方面的有效性较为有限。可能的原因包括轻度NCD参与者的异质性更大,以及如何解释和实施DSM-5轻度NCD标准中的“量化临床评估”。